Angiography Catheters Market

Market Overview

The global angiography catheters market size was valued at USD 1.42 billion in 2022. It is projected to reach USD 2.91 billion by 2031, growing at a CAGR of 8.3% during the forecast period (2023–2031). Factors such as increase in household income and rising prevalence of cardiovascular illnesses, significantly drives the angiography catheters market demand by 2031.

Catheter angiography uses a catheter, x-ray imaging guidance, and the injection of contrast material to examine blood arteries in significant body areas for anomalies like aneurysms and illnesses like atherosclerosis. It is available in various cambers and is made for extreme reenactment. An angiographic procedure uses a plastic tube known as an angiography catheter. The angiography catheter's primary function is to deliver therapeutic agents and radiopaque material into the body. This is delivered to particular body parts. Using the catheter inserter, the catheter tip can be made straight. It is simpler to insert the catheter tip into the sheath if it is straightened. A guidewire can be guided to the desired location using the implanted or pigtail catheter. During catheter angiography, a catheter and a small plastic conduit are introduced into a vein through a tiny skin scrape. Medical professionals typically use angiographic catheters to locate aneurysms, diagnose artery disease, or direct interventional radiologists and surgeons. At the same time, they treat sick blood vessels by implanting stents or monitoring the state of a stent that has already been placed.

Market Dynamics

Angiography Catheters Market Drivers

An Increase in Household Income

The need for angiographic catheters will increase as domestic income levels rise. Due to rising domestic income, people can spend more on healthcare, and reimbursement policies make it simpler for patients to accept treatments. The government's increasing efforts to raise public awareness will also significantly impact the angiography catheter market growth rate for angiographic catheters. Technology development is another essential aspect contributing to the expansion of the industry. Additionally, the market will grow due to an increase in older adults and their preference for minimally invasive procedures. The market for angiographic catheters will experience slower growth due to rising tobacco, alcohol, and drug use.

The Prevalence of Cardiovascular Illnesses Is Rising

The burden of cardiovascular illnesses is growing significantly with the number of diabetics and the adoption of unhealthy lifestyles. A significant factor driving the growth of the global angiography catheter market is the rise in the number of cardiac operations conducted globally. The area of cardiology has been driven by the advent of numerous new technologies and the expanding usage of advanced technology, such as angiography catheterization, due to the rising prevalence of cardiovascular disease. Due to expanding disposable income, higher spending capacity, and favorable reimbursement policies, consumers are increasingly convinced to embrace innovative healthcare equipment. Other reasons supporting the market's expansion include a significant increase in catheterization labs, a growing preference for minimally invasive treatments, and a rise in cardiovascular disease patients.

Angiography Catheters Market Restraints

High Risk Involved in Angiographic Surgery Procedures

An allergic reaction to foreign substances or medications used during catheterization is one of the hazards associated with the procedure. The angiographic catheter market faces a significant challenge since there may be bleeding, infection, bruising, and blood clots in the capillaries at the catheter attachment site, which can result in a heart attack, stroke, or other serious illnesses. On the other hand, the high cost of angiographic procedures will restrain market expansion. The market for angiographic catheters will also face significant challenges from rigorous government regulations related to product approval. However, the unorthodox nature of therapies and their limited availability will restrain and further hamper the market's growth pace during the projection period.

Angiography Catheters Market Opportunities

Technological Advancements and Growth in R&D

The growth of the angiographic catheter market will benefit from the increase in research and development activities. Most research and development efforts focus on a method that pinpoints the exact location of bleeding and can be used for embolization or vasopressin therapy. In addition, the future growth rate of the angiographic catheter market will be further accelerated by the acceleration of technological development in medical devices. With the aid of more advanced technologies, angiograms give a precise picture of the blood vessels, which is advantageous for market expansion. Most research and development initiatives focus on a method that pinpoints the precise site of bleeding and can be utilized to make medical decisions about vasopressin or embolization. In this technique, the bowel does not need to be prepared. An accurate picture of the blood vessels is shown by angiography with cutting-edge technology, providing lucrative growth for the market.

Regional Analysis

The global angiography catheters market share is bifurcated into four regions: North America, Europe, Asia-Pacific, and LAMEA.

North America Dominates the Global Market.

North America is the most significant shareholder in the global market for angiography catheter and is expected to grow at a CAGR of 7.6% during the forecast period. The U.S. and Canada are included in the analysis of the angiography catheter market in North America. Due to the rising senior population and the frequency of CVDs, North America will probably grow even more. Significant corporations' presence in the United States contributes to their dominant market share. Some American firms that manufacture angiography equipment include GE Healthcare, Philips Healthcare, Boston Scientific Corporation, Abbott Laboratories, AngioDynamics, Inc., Cordis Corp., Carestream Health, and Hologic, Inc. Because there are so many domestic and international manufacturers there, Europe is likewise expected to experience tremendous growth in the upcoming years. The regional market is anticipated to be driven by the rising demand for cutting-edge medical equipment and the prevalence of CVD.

Asia Pacific is expected to grow at a CAGR of 8.9% during the forecast period. China, India, Japan, Australia, and the rest of Asia-Pacific are all included in the analysis of the Asia-Pacific angiography catheter market. The availability of inexpensive goods, reasonable medical care, and rising tourism in the area are to blame. The region’s development is supported by the Japanese government's favorable reimbursement policies, which encourage technological developments. In nations like South Korea, Brazil, and India, the regulatory environment is less strict, providing an alluring opportunity for multinational corporations to establish their presence in these markets. China is consolidating its economy to improve its machinery’s caliber. The most significant market participants, including GE Healthcare, Siemens Healthcare, and Koninklijke Philips N.V., are increasing their imports, boosting the growth of the China angiography market.

Segmental Analysis

The market is segmented by product, application, and end user.

Based on the product, the global angiography catheter market is bifurcated into conventional catheters, DEB catheters, scoring balloon catheters, and cutting balloon catheters.

The conventional catheters segment is the highest contributor to the market and is expected to grow at a CAGR of 8.2% during the forecast period. Standard intra-arterial catheter angiography is typically carried out while receiving a local anesthetic. Under the guidance of a fluoroscope, a catheter is inserted through the femoral artery into the neck's internal carotid and vertebral arteries. Images are quickly captured in succession after contrast injection. Images of the contrast-filled vessels are produced by digital subtraction, which excludes background structures like bone.

Based on application, the global angiography catheter market is bifurcated into coronary, endovascular, neurology, oncology, and others.

The coronary segment is the highest contributor to the market and is expected to grow at a CAGR of 8.6% during the forecast period. The demand for coronary angiography is increasing in emerging nations like China and India due to the rising prevalence of coronary artery disease (CAD) and the accessibility of less-invasive imaging techniques. The ability to effectively diagnose the condition has been made possible by ongoing advancements in imaging technology. It has been noted that the imaging technique has changed from single-slice CT to multislice CT, which provides excellent CAD visualization and assessment. Coronary CT angiography, cardiac MRI, cardiac single photon emission computed tomography (SPECT), cardiac positron emission tomography (PET), integrated SPECT/CT, and PET/CT are a few diagnostic methods available.

Based on end users, the global angiography catheter market is bifurcated into hospitals, ambulatory surgical centers, and specialty clinics.

The hospital segment is the highest contributor to the market and is expected to grow at a CAGR of 8.17% during the forecast period. Due to their superior facilities and care, hospitals can command the most significant market share. The move toward computerized cath labs in hospitals and the rise in cardiac disease incidence is to blame. A more significant healthcare substructure, the availability of a competent workforce, and the cost of the materials used to make catheters are all contributing reasons to the expansion of this market. Another factor influencing the growth of this market is the escalation in an enduring puddle, which is due to a significant increase in the geriatric population suffering from lifestyle disorders like atherosclerosis and heart failure disease and is anticipated to increase hospital income production.

Recent Developments

• October 2022, when used with a compatible multi-channel RF generator, the HELIOSTAR Balloon Ablation Catheter is indicated for cardiac ablation and catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria.

• March 2022, The CATHIS RHC 2, which was created in collaboration with the German Cologne Cardiovascular Research Center, includes all the characteristics of CATHI's first RHC simulator, wire-assisted navigation, and the ability to operate with actual liquids, which enables thermodilution.